These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14612540)

  • 1. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity.
    Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI
    Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9.
    Cai D; Byth KF; Shapiro GI
    Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective sensitization of transformed cells to flavopiridol-induced apoptosis following recruitment to S-phase.
    Matranga CB; Shapiro GI
    Cancer Res; 2002 Mar; 62(6):1707-17. PubMed ID: 11912144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
    Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
    Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
    Shan B; Farmer AA; Lee WH
    Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavopiridol-induced apoptosis is mediated through up-regulation of E2F1 and repression of Mcl-1.
    Ma Y; Cress WD; Haura EB
    Mol Cancer Ther; 2003 Jan; 2(1):73-81. PubMed ID: 12533675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway.
    Nguyen DM; Schrump WD; Tsai WS; Chen A; Stewart JH; Steiner F; Schrump DS
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1132-42. PubMed ID: 12771887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol increases sensitization to gemcitabine in human gastrointestinal cancer cell lines and correlates with down-regulation of ribonucleotide reductase M2 subunit.
    Jung CP; Motwani MV; Schwartz GK
    Clin Cancer Res; 2001 Aug; 7(8):2527-36. PubMed ID: 11489836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
    Li W; Fan J; Bertino JR
    Cancer Res; 2001 Mar; 61(6):2579-82. PubMed ID: 11289134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
    Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and modulation of cerebellar granule neuron death by E2F-1.
    O'Hare MJ; Hou ST; Morris EJ; Cregan SP; Xu Q; Slack RS; Park DS
    J Biol Chem; 2000 Aug; 275(33):25358-64. PubMed ID: 10851232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J; Hiebert SW
    Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.